Overcoming Resistance to HER2-Directed Therapies in Breast Cancer

SIMPLE SUMMARY: Breast cancer is the most common cancer in women in the United States. Around 15% of all breast cancers overexpress the HER2 protein. These HER2-positive tumors have been associated with aggressive behavior if left untreated. Drugs targeting HER2 have greatly improved the outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlam, Ilana, Tarantino, Paolo, Tolaney, Sara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406173/
https://www.ncbi.nlm.nih.gov/pubmed/36010990
http://dx.doi.org/10.3390/cancers14163996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406173/
https://www.ncbi.nlm.nih.gov/pubmed/36010990
http://dx.doi.org/10.3390/cancers14163996

Ejemplares similares